Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.04 trillion and total revenue of $110.14 billion.
Market Cap
1.04T
Revenue
110.14B
Profits
-41.3B
PE Ratio
n/a
Profit Margin
-37.50%
Dividend Yield
0.05%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.01B | -4.56% | 1,917,591 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.99B | -2.51% | 357,201 | 14.34B |
| 3 | ARGX | argenx SE | 42.79B | -0.21% | 418,902 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.09B | -3.29% | 666,025 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.37B | 2.20% | 233,728 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.32B | -1.56% | 3,400,620 | 606.42M |
| 7 | BNTX | BioNTech SE | 21.53B | -2.07% | 697,815 | 3.37B |
| 8 | RPRX | Royalty Pharma plc | 19.86B | -1.26% | 2,685,321 | 2.38B |
| 9 | MRNA | Moderna, Inc. | 19.57B | -7.49% | 7,044,937 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 18.98B | -3.03% | 2,981,197 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.33B | -0.75% | 1,101,724 | - |
| 12 | INCY | Incyte Corporation | 17.97B | -2.12% | 1,488,036 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.59B | -0.81% | 1,815,650 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.52B | -3.95% | 975,970 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.31B | -1.67% | 579,432 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.86B | -3.94% | 2,071,397 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.92B | -2.82% | 1,937,376 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.71B | -1.59% | 485,036 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.25B | -3.42% | 820,110 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.78B | -1.97% | 1,383,787 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -2.54% | 1,037,077 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.08B | -5.05% | 1,413,178 | 1.09B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.08B | -4.16% | 357,513 | 7.46M |
| 24 | ABVX | ABIVAX Société Anonyme | 8.05B | -6.40% | 1,697,086 | 5.37M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.00B | -4.82% | 599,949 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 7.97B | -3.32% | 1,776,081 | 1.22B |
| 27 | CYTK | Cytokinetics, Incorporated | 7.70B | -1.54% | 1,473,973 | 88.04M |
| 28 | PCVX | Vaxcyte, Inc. | 7.65B | -2.83% | 806,625 | - |
| 29 | NUVL | Nuvalent, Inc. | 7.60B | -1.40% | 395,655 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.59B | - | 14,285,689 | 113.29M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.27B | -2.62% | 1,274,569 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.17B | -2.39% | 288,148 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.04% | 1,586,962 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.38B | -2.52% | 566,577 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.32B | -3.13% | 611,128 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.01B | 2.47% | 109,721 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 5.86B | -2.09% | 1,277,564 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.47B | -1.30% | 1,013,020 | 1.73B |
| 39 | CGON | CG Oncology, Inc. | 5.46B | -3.07% | 729,585 | 4.04M |
| 40 | APGE | Apogee Therapeutics, Inc. | 5.41B | -0.77% | 969,910 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -0.50% | 713,100 | 521.31M |
| 42 | XENE | Xenon Pharmaceuticals Inc. | 5.20B | -1.89% | 827,193 | 7.50M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.18B | -7.42% | 1,418,629 | 189.76M |
| 44 | CELC | Celcuity Inc. | 5.12B | -7.66% | 756,033 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 5.07B | -0.72% | 1,266,194 | 616.29M |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.89B | -3.64% | 903,106 | - |
| 47 | IMVT | Immunovant, Inc. | 4.88B | -5.44% | 956,650 | - |
| 48 | CAI | Caris Life Sciences, Inc. | 4.79B | -7.45% | 3,439,367 | 812.03M |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.77B | -0.47% | 7,921,173 | - |
| 50 | ERAS | Erasca, Inc. | 4.65B | -1.25% | 3,530,306 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.10% | 1,889,164 | 634.21M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.39B | -3.79% | 1,581,210 | 3.51M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.00B | -2.41% | 1,765,493 | 761.41M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 3.90B | -4.03% | 228,161 | 268.09M |
| 55 | CNTA | Centessa Pharmaceuticals plc | 3.86B | -2.38% | 1,299,204 | 15.00M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.76B | -5.05% | 1,970,046 | - |
| 57 | SYRE | Spyre Therapeutics, Inc. | 3.72B | -0.39% | 720,440 | - |
| 58 | DNTH | Dianthus Therapeutics, Inc. | 3.61B | -1.60% | 879,887 | 2.04M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | -3.35% | 934,722 | 1.07B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.53B | -7.27% | 1,452,189 | 7.70M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.45B | -4.06% | 737,981 | 22.50M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.31B | -2.56% | 561,834 | - |
| 63 | GPCR | Structure Therapeutics Inc. | 3.25B | -0.64% | 1,192,220 | - |
| 64 | ALMS | Alumis Inc. | 3.15B | -5.78% | 1,404,071 | 24.05M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.12B | 2.56% | 269,227 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.11B | -3.95% | 1,171,755 | 1.03B |
| 67 | DNLI | Denali Therapeutics Inc. | 2.88B | -7.98% | 3,056,252 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.86B | -3.51% | 527,990 | 588.99M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.83B | -7.60% | 1,763,867 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | -1.41% | 297,388 | 451.36M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -2.87% | 1,116,837 | 70.85M |
| 72 | VERA | Vera Therapeutics, Inc. | 2.77B | -3.48% | 752,386 | - |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.75B | -3.02% | 1,620,788 | 62.38M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.67B | -5.08% | 550,257 | 218.71M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.63B | -5.18% | 1,084,936 | 376.07M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.54B | -4.38% | 554,319 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.51B | -2.40% | 464,638 | 490.73M |
| 78 | MANE | Veradermics, Incorporated | 2.45B | -2.99% | 261,734 | - |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.32B | -1.09% | 1,345,542 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.29B | -3.10% | 316,465 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.26B | -6.05% | 2,297,200 | 139.74M |
| 82 | IMNM | Immunome, Inc. | 2.22B | -3.92% | 933,229 | 6.94M |
| 83 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 1,561,724 | 158.18M |
| 84 | ORKA | Oruka Therapeutics, Inc. | 2.20B | -2.16% | 811,113 | - |
| 85 | ADMA | ADMA Biologics, Inc. | 2.20B | 11.58% | 22,231,655 | 510.17M |
| 86 | APLS | Apellis Pharmaceuticals, Inc. | 2.17B | -3.80% | 1,755,951 | 1.00B |
| 87 | AAPG | Ascentage Pharma Group International | 2.14B | 8.19% | 3,735 | 82.08M |
| 88 | SRPT | Sarepta Therapeutics, Inc. | 2.10B | -7.89% | 4,209,718 | 2.20B |
| 89 | SNDX | Syndax Pharmaceuticals, Inc. | 2.07B | -4.90% | 1,221,912 | 172.35M |
| 90 | CLDX | Celldex Therapeutics, Inc. | 2.02B | -4.57% | 714,171 | 1.55M |
| 91 | ZLAB | Zai Lab Limited | 1.99B | 2.80% | 665,119 | 460.16M |
| 92 | NKTR | Nektar Therapeutics | 1.97B | -3.25% | 730,103 | 55.23M |
| 93 | KOD | Kodiak Sciences Inc. | 1.96B | -6.94% | 5,231,388 | - |
| 94 | TYRA | Tyra Biosciences, Inc. | 1.95B | -4.58% | 585,449 | - |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | 0.30% | 1,437,398 | - |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.94B | -2.52% | 383,907 | 184.42M |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 1.91B | -11.10% | 4,653,746 | 276.98M |
| 98 | GLPG | Galapagos NV | 1.91B | -3.47% | 371,321 | 1.31B |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | -2.16% | 918,571 | 283.06M |
| 100 | RARE | Ultragenyx Pharmaceutical Inc. | 1.87B | -3.10% | 1,236,294 | 673.00M |
| 101 | MESO | Mesoblast Limited | 1.85B | -3.36% | 172,068 | 65.38M |
| 102 | ZYME | Zymeworks Inc. | 1.78B | -2.07% | 374,766 | 105.97M |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.78B | -5.60% | 1,549,882 | - |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | -1.74% | 659,695 | 54.03M |
| 105 | RLAY | Relay Therapeutics, Inc. | 1.72B | -4.84% | 1,673,546 | 15.36M |
| 106 | INVA | Innoviva, Inc. | 1.67B | -0.22% | 491,940 | 411.33M |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.66B | -3.51% | 905,707 | 11.13M |
| 108 | ANAB | AnaptysBio, Inc. | 1.65B | -11.68% | 1,285,820 | 234.60M |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.64B | -6.44% | 2,802,061 | 51.95M |
| 110 | SION | Sionna Therapeutics, Inc. | 1.62B | -4.93% | 470,417 | - |
| 111 | SLNO | Soleno Therapeutics, Inc. | 1.55B | -5.68% | 1,528,745 | 190.41M |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.55B | -6.67% | 18,962,191 | 74.68M |
| 113 | DMRA | Damora Therapeutics, Inc. | 1.54B | -0.51% | 156,565 | - |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.54B | -3.28% | 677,885 | 868.45M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.52B | -4.96% | 1,170,482 | 83.98M |
| 116 | MAZE | Maze Therapeutics, Inc. | 1.51B | -4.19% | 1,637,600 | 2.50M |
| 117 | PHVS | Pharvaris N.V. | 1.50B | 0.04% | 73,880 | - |
| 118 | IMCR | Immunocore Holdings plc | 1.49B | -3.51% | 297,819 | 400.02M |
| 119 | VCEL | Vericel Corporation | 1.49B | -4.80% | 611,060 | 276.26M |
| 120 | NUVB | Nuvation Bio Inc. | 1.48B | -3.85% | 4,138,647 | 62.90M |
| 121 | NBTX | Nanobiotix S.A. | 1.46B | -3.44% | 66,579 | 11.93M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.46B | -6.57% | 3,372,070 | 67.67M |
| 123 | OCS | Oculis Holding AG | 1.46B | -1.32% | 119,699 | 1.51M |
| 124 | GENB | Generate Biomedicines, Inc. | 1.46B | -10.97% | 274,763 | 31.89M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.45B | -3.98% | 1,133,781 | - |
| 126 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.88% | 8,418,515 | 263.50M |
| 127 | NVAX | Novavax, Inc. | 1.38B | -5.59% | 2,631,319 | 1.12B |
| 128 | MBX | MBX Biosciences, Inc. | 1.35B | 0.74% | 351,223 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.34B | -3.69% | 2,121,631 | 407.32M |
| 130 | PVLA | Palvella Therapeutics, Inc. | 1.33B | -4.46% | 193,881 | - |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.33B | -4.10% | 289,549 | - |
| 132 | PGEN | Precigen, Inc. | 1.30B | -5.66% | 6,338,138 | 9.68M |
| 133 | BHVN | Biohaven Ltd. | 1.26B | -6.17% | 1,345,590 | - |
| 134 | IMTX | Immatics N.V. | 1.26B | -4.09% | 272,586 | 56.67M |
| 135 | MLTX | MoonLake Immunotherapeutics | 1.24B | -2.34% | 415,585 | - |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -1.85% | 989,172 | 123.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.22B | -5.37% | 3,114,262 | 4.09M |
| 138 | ORIC | ORIC Pharmaceuticals, Inc. | 1.21B | -2.58% | 1,342,898 | - |
| 139 | WVE | Wave Life Sciences Ltd. | 1.20B | 2.66% | 13,415,497 | 42.73M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -3.19% | 1,019,343 | - |
| 141 | DBVT | DBV Technologies S.A. | 1.18B | -1.04% | 275,602 | 5.64M |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -0.43% | 1,113,529 | - |
| 143 | VIR | Vir Biotechnology, Inc. | 1.17B | -6.25% | 1,182,981 | 68.56M |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | -5.79% | 1,910,650 | 9.77M |
| 145 | PHAR | Pharming Group N.V. | 1.10B | -1.47% | 26,404 | 376.13M |
| 146 | SEPN | Septerna, Inc. | 1.07B | -3.52% | 123,987 | 45.95M |
| 147 | SVRA | Savara Inc. | 1.05B | -2.00% | 1,344,450 | - |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -17.82% | 3,364,235 | 10.00M |
| 149 | EYPT | EyePoint, Inc. | 1.04B | -4.29% | 627,653 | 31.37M |
| 150 | BCAX | Bicara Therapeutics Inc. | 1.01B | -2.91% | 586,843 | - |
| 151 | ABCL | AbCellera Biologics Inc. | 991.33M | -2.39% | 2,269,378 | 75.13M |
| 152 | KALV | KalVista Pharmaceuticals, Inc. | 977.06M | 2.01% | 2,061,348 | 73.62M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 948.57M | -1.58% | 361,517 | - |
| 154 | CMPX | Compass Therapeutics, Inc. | 938.26M | -2.25% | 1,091,596 | 850.00K |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 931.99M | -2.96% | 1,318,683 | 291.85M |
| 156 | QURE | uniQure N.V. | 923.56M | -5.32% | 1,332,776 | 16.10M |
| 157 | GERN | Geron Corporation | 896.76M | -9.09% | 18,286,517 | 183.88M |
| 158 | TVGN | Tevogen Bio Holdings Inc. | 883.55M | -8.30% | 38,591 | - |
| 159 | INBX | Inhibrx Biosciences, Inc. | 850.64M | -11.48% | 282,414 | 1.30M |
| 160 | FTRE | Fortrea Holdings Inc. | 845.71M | -5.29% | 613,469 | 2.72B |
| 161 | URGN | UroGen Pharma Ltd. | 839.53M | -3.66% | 687,922 | 109.79M |
| 162 | ABUS | Arbutus Biopharma Corporation | 838.60M | -3.60% | 1,208,524 | 14.08M |
| 163 | XNCR | Xencor, Inc. | 837.53M | -7.23% | 701,299 | 125.58M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 833.69M | -1.95% | 1,377,914 | 175.11M |
| 165 | MPLT | MapLight Therapeutics, Inc. | 820.61M | -3.07% | 225,012 | - |
| 166 | GHRS | GH Research PLC | 815.69M | -6.67% | 87,182 | - |
| 167 | JANX | Janux Therapeutics, Inc. | 801.76M | -3.30% | 1,306,949 | 10.00M |
| 168 | SPRY | ARS Pharmaceuticals, Inc. | 801.33M | -5.72% | 2,168,920 | 84.28M |
| 169 | IVA | Inventiva S.A. | 800.12M | -5.58% | 175,197 | 19.93M |
| 170 | EVMN | Evommune, Inc. | 798.89M | -6.29% | 185,883 | 13.00M |
| 171 | AKTS | Aktis Oncology, Inc. | 797.81M | -13.79% | 536,932 | 5.56M |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 783.88M | -11.82% | 10,106,411 | - |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 777.76M | -6.00% | 605,482 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 776.51M | -0.72% | 486,603 | 107.46M |
| 175 | CTMX | CytomX Therapeutics, Inc. | 769.24M | 2.26% | 7,519,155 | 76.20M |
| 176 | SGP | SpyGlass Pharma, Inc. | 753.31M | -10.28% | 95,373 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 739.22M | -8.58% | 2,573,736 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 716.19M | -4.53% | 146,898 | - |
| 179 | ANL | Adlai Nortye Ltd. | 715.13M | -4.30% | 117,381 | -1.35M |
| 180 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.69M | -3.79% | 133,873 | - |
| 181 | MNKD | MannKind Corporation | 702.47M | -0.87% | 5,552,914 | 348.97M |
| 182 | OMER | Omeros Corporation | 700.50M | -4.08% | 789,286 | - |
| 183 | SLDB | Solid Biosciences Inc. | 699.56M | -8.02% | 745,868 | - |
| 184 | LXRX | Lexicon Pharmaceuticals, Inc. | 699.07M | 1.23% | 1,668,420 | 49.80M |
| 185 | KURA | Kura Oncology, Inc. | 683.67M | -7.42% | 2,190,578 | 67.48M |
| 186 | RLMD | Relmada Therapeutics, Inc. | 672.35M | -1.84% | 709,992 | - |
| 187 | JBIO | Jade Biosciences, Inc. | 660.35M | -4.01% | 180,780 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 657.41M | -3.69% | 146,083 | 116.59M |
| 189 | ANRO | Alto Neuroscience, Inc. | 654.88M | -1.54% | 182,877 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 650.03M | -1.59% | 168,542 | - |
| 191 | ARVN | Arvinas, Inc. | 646.01M | -7.08% | 673,765 | 262.60M |
| 192 | MGTX | MeiraGTx Holdings plc | 613.34M | 1.20% | 540,356 | 81.39M |
| 193 | OCGN | Ocugen, Inc. | 613.17M | -4.59% | 6,207,017 | 4.41M |
| 194 | PRME | Prime Medicine, Inc. | 610.27M | -7.14% | 3,699,324 | 4.63M |
| 195 | DRTS | Alpha Tau Medical Ltd. | 603.75M | -0.58% | 236,186 | - |
| 196 | LBRX | LB Pharmaceuticals Inc | 603.13M | -2.81% | 173,441 | - |
| 197 | ANNX | Annexon, Inc. | 598.16M | -4.76% | 1,471,315 | - |
| 198 | REPL | Replimune Group, Inc. | 596.17M | -4.24% | 1,044,935 | - |
| 199 | MDXG | MiMedx Group, Inc. | 566.04M | -3.30% | 1,066,399 | 418.63M |
| 200 | YDES | YD Bio Limited | 562.76M | 3.23% | 1,899 | 510.36K |
| 201 | ZURA | Zura Bio Limited | 562.64M | -1.82% | 676,136 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 551.09M | -4.58% | 143,312 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 550.94M | -6.22% | 5,910,058 | 22.00K |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 537.80M | -2.55% | 435,599 | 106.47M |
| 205 | VALN | Valneva SE | 535.85M | -2.22% | 27,121 | 205.07M |
| 206 | CRMD | CorMedix Inc. | 530.82M | 0.22% | 1,322,648 | 311.71M |
| 207 | EIKN | Eikon Therapeutics, Inc. | 529.59M | -6.84% | 179,365 | - |
| 208 | AGMB | AgomAb Therapeutics NV | 528.79M | -8.59% | 64,628 | - |
| 209 | PRTA | Prothena Corporation plc | 498.49M | -2.73% | 355,376 | 9.68M |
| 210 | CTNM | Contineum Therapeutics, Inc. | 498.06M | -2.27% | 161,821 | - |
| 211 | LRMR | Larimar Therapeutics, Inc. | 479.94M | -4.74% | 959,303 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 477.35M | -2.01% | 269,240 | 294.28M |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 476.06M | -8.40% | 939,604 | 85.21M |
| 214 | KYTX | Kyverna Therapeutics, Inc. | 471.43M | -2.86% | 657,526 | - |
| 215 | UPB | Upstream Bio, Inc. | 470.73M | -11.64% | 938,044 | 2.85M |
| 216 | ADCT | ADC Therapeutics SA | 470.06M | -6.57% | 934,840 | 81.36M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 459.38M | -2.52% | 38,704 | 36.00K |
| 218 | TRDA | Entrada Therapeutics, Inc. | 456.73M | -3.09% | 111,671 | 25.42M |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 448.22M | -3.03% | 290,330 | 80.00M |
| 220 | VSTM | Verastem, Inc. | 442.69M | -4.73% | 1,383,333 | 30.91M |
| 221 | NAUT | Nautilus Biotechnology, Inc. | 439.54M | -7.94% | 422,914 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 439.40M | -4.05% | 66,303 | 72.30M |
| 223 | IMMX | Immix Biopharma, Inc. | 432.24M | -6.41% | 699,343 | - |
| 224 | STTK | Shattuck Labs, Inc. | 430.82M | -4.60% | 512,519 | 1.00M |
| 225 | ENGN | enGene Holdings Inc. | 426.72M | -8.48% | 151,437 | - |
| 226 | ABSI | Absci Corporation | 425.40M | -3.47% | 4,196,511 | 2.80M |
| 227 | ACRS | Aclaris Therapeutics, Inc. | 424.50M | - | 2,310,695 | 7.83M |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 419.28M | -1.90% | 77,901 | - |
| 229 | MRVI | Maravai LifeSciences Holdings, Inc. | 418.66M | -7.44% | 2,306,361 | 185.74M |
| 230 | CBIO | Crescent Biopharma, Inc. | 418.31M | 12.44% | 390,329 | 10.84M |
| 231 | RCKT | Rocket Pharmaceuticals, Inc. | 409.31M | -19.62% | 23,058,278 | - |
| 232 | VNDA | Vanda Pharmaceuticals Inc. | 408.44M | -2.95% | 1,066,834 | 216.11M |
| 233 | STRO | Sutro Biopharma, Inc. | 408.22M | -1.08% | 86,182 | 102.48M |
| 234 | AVIR | Atea Pharmaceuticals, Inc. | 407.92M | -3.94% | 280,790 | - |
| 235 | RGNX | REGENXBIO Inc. | 400.52M | -6.05% | 532,684 | 170.44M |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 398.51M | -3.36% | 768,543 | - |
| 237 | AURA | Aura Biosciences, Inc. | 398.17M | -2.64% | 244,838 | - |
| 238 | ALT | Altimmune, Inc. | 392.81M | -5.63% | 2,349,416 | 41.00K |
| 239 | NMRA | Neumora Therapeutics, Inc. | 389.32M | -6.43% | 945,482 | - |
| 240 | IVVD | Invivyd, Inc. | 387.15M | -9.27% | 2,351,858 | 53.43M |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 371.14M | -2.61% | 980,738 | 14.56M |
| 242 | PRTC | PureTech Health plc | 369.51M | -2.35% | 9,093 | 6.39M |
| 243 | PLYX | Polaryx Therapeutics, Inc. | 368.80M | 22.10% | 2,593,436 | - |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 367.32M | -6.26% | 319,872 | 35.11M |
| 245 | MNPR | Monopar Therapeutics Inc. | 363.38M | -0.48% | 184,310 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 363.04M | -1.94% | 1,480,659 | 109.16M |
| 247 | XOMA | XOMA Royalty Corporation | 359.19M | -1.18% | 87,684 | 52.15M |
| 248 | DMAC | DiaMedica Therapeutics Inc. | 353.61M | -0.88% | 163,743 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 353.46M | -2.64% | 97,738 | 66.98M |
| 250 | CADL | Candel Therapeutics, Inc. | 353.42M | -1.13% | 1,255,468 | - |
| 251 | BNTC | Benitec Biopharma Inc. | 353.16M | -4.90% | 71,263 | - |
| 252 | DNA | Ginkgo Bioworks Holdings, Inc. | 349.42M | -7.49% | 1,545,316 | 170.16M |
| 253 | NAGE | Niagen Bioscience, Inc. | 336.34M | -6.04% | 869,275 | 129.42M |
| 254 | CLYM | Climb Bio, Inc. | 333.66M | -1.76% | 357,908 | - |
| 255 | SRZN | Surrozen, Inc. | 331.97M | 3.21% | 71,229 | 3.48M |
| 256 | PALI | Palisade Bio, Inc. | 331.77M | 2.04% | 3,485,988 | - |
| 257 | AUTL | Autolus Therapeutics plc | 322.03M | -6.20% | 4,812,000 | 75.39M |
| 258 | IMRX | Immuneering Corporation | 320.68M | -4.98% | 452,850 | - |
| 259 | FBRX | Forte Biosciences, Inc. | 319.44M | -5.59% | 274,607 | - |
| 260 | NGNE | Neurogene Inc. | 316.94M | -4.95% | 121,510 | 925.00K |
| 261 | AVTX | Avalo Therapeutics, Inc. | 316.76M | -0.36% | 528,122 | 59.00K |
| 262 | PEPG | PepGen Inc. | 312.40M | -7.57% | 347,963 | - |
| 263 | IRD | Opus Genetics, Inc. | 310.57M | -3.43% | 321,604 | 14.20M |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 309.37M | -11.88% | 199,359 | - |
| 265 | PBYI | Puma Biotechnology, Inc. | 309.33M | -3.03% | 203,743 | 228.37M |
| 266 | ARMP | Armata Pharmaceuticals, Inc. | 306.62M | -10.48% | 26,753 | 4.90M |
| 267 | OVID | Ovid Therapeutics Inc. | 303.31M | -6.50% | 1,950,103 | 7.25M |
| 268 | BCYC | Bicycle Therapeutics plc | 300.44M | -4.22% | 841,512 | 72.59M |
| 269 | CABA | Cabaletta Bio, Inc. | 298.34M | -4.96% | 2,799,137 | - |
| 270 | NBP | NovaBridge Biosciences | 292.84M | -0.39% | 462,127 | - |
| 271 | RZLT | Rezolute, Inc. | 286.14M | -8.00% | 2,048,810 | - |
| 272 | ACIU | AC Immune SA | 274.79M | -6.57% | 258,440 | 4.51M |
| 273 | NERV | Minerva Neurosciences, Inc. | 269.17M | 1.30% | 167,774 | - |
| 274 | ALXO | ALX Oncology Holdings Inc. | 268.48M | - | 259,406 | - |
| 275 | TARA | Protara Therapeutics, Inc. | 267.18M | -4.82% | 575,579 | - |
| 276 | FHTX | Foghorn Therapeutics Inc. | 264.15M | -8.16% | 85,349 | 30.91M |
| 277 | LENZ | LENZ Therapeutics, Inc. | 263.38M | -6.04% | 1,378,799 | 19.09M |
| 278 | AVXL | Anavex Life Sciences Corp. | 261.33M | -2.08% | 2,428,692 | - |
| 279 | TENX | Tenax Therapeutics, Inc. | 257.45M | - | 351,311 | - |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 249.30M | -5.12% | 123,779 | 33.48M |
| 281 | ENLV | Enlivex Ltd. | 249.25M | -3.67% | 224,134 | - |
| 282 | ABEO | Abeona Therapeutics Inc. | 244.74M | -0.92% | 1,165,541 | 5.82M |
| 283 | CHRS | Coherus Oncology, Inc. | 244.32M | -1.81% | 607,130 | 42.17M |
| 284 | CLLS | Cellectis S.A. | 238.62M | -3.45% | 19,816 | 79.59M |
| 285 | CNTX | Context Therapeutics Inc. | 237.97M | 1.97% | 679,013 | - |
| 286 | VYGR | Voyager Therapeutics, Inc. | 236.01M | -4.12% | 364,478 | 40.37M |
| 287 | CCCC | C4 Therapeutics, Inc. | 235.16M | -8.02% | 1,599,291 | 35.95M |
| 288 | SLN | Silence Therapeutics plc | 232.86M | -7.16% | 304,909 | 559.00K |
| 289 | PROK | ProKidney Corp. | 227.11M | -9.60% | 1,480,775 | 893.00K |
| 290 | HELP | Cybin Inc. | 226.16M | -2.80% | 530,734 | - |
| 291 | CAMP | Camp4 Therapeutics Corporation | 223.77M | -5.48% | 57,027 | 3.50M |
| 292 | IKT | Inhibikase Therapeutics, Inc. | 221.81M | 3.07% | 762,143 | 1.00 |
| 293 | ALEC | Alector, Inc. | 220.73M | -5.66% | 466,450 | 21.05M |
| 294 | OABI | OmniAb, Inc. | 218.62M | -4.43% | 194,014 | 18.67M |
| 295 | EDIT | Editas Medicine, Inc. | 218.25M | -3.88% | 1,564,036 | 40.52M |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 216.62M | - | 61,789 | 19.39M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 215.42M | -4.05% | 853,886 | - |
| 298 | KROS | Keros Therapeutics, Inc. | 210.09M | -3.84% | 297,665 | 244.06M |
| 299 | FENC | Fennec Pharmaceuticals Inc. | 201.90M | -9.22% | 179,180 | 44.64M |
| 300 | NVCT | Nuvectis Pharma, Inc. | 198.16M | -4.23% | 62,433 | - |
| 301 | SABS | SAB Biotherapeutics, Inc. | 196.16M | 0.52% | 724,578 | 114.70K |
| 302 | CNTB | Connect Biopharma Holdings Limited | 193.43M | -6.23% | 347,219 | 762.00K |
| 303 | MDWD | MediWound Ltd. | 193.17M | -4.20% | 123,200 | 16.96M |
| 304 | CGEN | Compugen Ltd. | 192.89M | -0.97% | 141,747 | 72.76M |
| 305 | PRLD | Prelude Therapeutics Incorporated | 192.16M | -5.86% | 114,515 | 12.14M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.14M | -4.52% | 607,385 | 82.03M |
| 307 | ELTX | Elicio Therapeutics, Inc. | 192.06M | -3.51% | 80,483 | - |
| 308 | MGNX | MacroGenics, Inc. | 186.22M | -7.86% | 935,222 | 149.50M |
| 309 | ADAG | Adagene Inc. | 177.68M | -8.94% | 134,785 | 103.20K |
| 310 | GALT | Galectin Therapeutics Inc. | 172.79M | -4.29% | 324,490 | - |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 172.66M | -6.33% | 766,005 | 13.11M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 172.10M | 1.42% | 716,637 | 52.74M |
| 313 | CRBU | Caribou Biosciences, Inc. | 171.05M | -7.33% | 892,560 | 11.16M |
| 314 | NTHI | NeOnc Technologies Holdings, Inc. | 164.97M | -0.14% | 23,148 | 59.99K |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 163.31M | -0.94% | 368,776 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 162.84M | -11.57% | 900,988 | - |
| 317 | SGMT | Sagimet Biosciences Inc. | 159.67M | -4.11% | 561,051 | - |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 155.08M | -3.78% | 311,480 | 2.80M |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 155.02M | -5.41% | 207,721 | - |
| 320 | VTVT | vTv Therapeutics Inc. | 151.68M | 1.88% | 32,588 | 17.00K |
| 321 | MOLN | Molecular Partners AG | 151.61M | -5.73% | 1,839 | 856.30K |
| 322 | VOR | Vor Biopharma Inc. | 150.80M | 6.74% | 1,584,021 | - |
| 323 | KRRO | Korro Bio, Inc. | 149.99M | -4.67% | 117,540 | 6.39M |
| 324 | WHWK | Whitehawk Therapeutics, Inc. | 149.14M | -11.48% | 159,060 | 7.15M |
| 325 | ZNTL | Zentalis Pharmaceuticals, Inc. | 148.96M | -21.35% | 1,127,364 | 26.87M |
| 326 | DTIL | Precision BioSciences, Inc. | 148.85M | -7.95% | 512,205 | 34.26M |
| 327 | HRTX | Heron Therapeutics, Inc. | 147.76M | -5.02% | 1,806,642 | 154.90M |
| 328 | NKTX | Nkarta, Inc. | 146.86M | -3.74% | 753,110 | - |
| 329 | EVAX | Evaxion A/S | 146.58M | -2.09% | 30,143 | 7.53M |
| 330 | PRQR | ProQR Therapeutics N.V. | 144.87M | -8.33% | 566,026 | 19.19M |
| 331 | MENS | Jyong Biotech Ltd. | 144.76M | -3.47% | 74,189 | - |
| 332 | TNYA | Tenaya Therapeutics, Inc. | 144.33M | -5.11% | 2,263,644 | - |
| 333 | CDXS | Codexis, Inc. | 143.57M | -4.82% | 852,185 | 70.39M |
| 334 | IMUX | Immunic, Inc. | 142.21M | -13.49% | 3,346,691 | - |
| 335 | ACHV | Achieve Life Sciences, Inc. | 141.09M | -8.30% | 1,230,044 | - |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 137.01M | -3.85% | 549,427 | - |
| 337 | FATE | Fate Therapeutics, Inc. | 136.03M | -4.88% | 1,082,270 | 6.65M |
| 338 | SPRO | Spero Therapeutics, Inc. | 134.89M | -1.69% | 484,770 | 66.80M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 133.27M | -0.75% | 101,294 | 2.00M |
| 340 | PMN | ProMIS Neurosciences, Inc. | 132.18M | -2.58% | 31,563 | - |
| 341 | ANTX | AN2 Therapeutics, Inc. | 131.54M | 1.39% | 250,637 | - |
| 342 | CBUS | Cibus, Inc. | 130.09M | -11.74% | 1,909,217 | 3.64M |
| 343 | AGEN | Agenus Inc. | 129.79M | -1.74% | 312,290 | 114.20M |
| 344 | MIST | Milestone Pharmaceuticals Inc. | 127.56M | -9.57% | 2,878,824 | 1.55M |
| 345 | HUMA | Humacyte, Inc. | 126.52M | -13.21% | 14,304,021 | 2.04M |
| 346 | ARTV | Artiva Biotherapeutics, Inc. | 123.58M | -3.10% | 167,172 | 251.00K |
| 347 | KLRS | Kalaris Therapeutics, Inc. | 123.01M | -7.82% | 172,065 | - |
| 348 | IPHA | Innate Pharma S.A. | 121.84M | 4.00% | 67,612 | 10.57M |
| 349 | EQ | Equillium, Inc. | 119.18M | -8.50% | 282,169 | 4.39M |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 116.30M | -4.69% | 430,579 | 70.00M |
| 351 | INO | Inovio Pharmaceuticals, Inc. | 111.24M | 3.87% | 1,467,872 | 65.34K |
| 352 | GNLX | Genelux Corporation | 111.12M | -5.70% | 136,218 | 8.00K |
| 353 | ACOG | Alpha Cognition Inc. | 110.45M | -4.87% | 111,421 | 10.22M |
| 354 | SGMO | Sangamo Therapeutics, Inc. | 107.98M | -6.74% | 6,828,622 | 32.88M |
| 355 | ALDX | Aldeyra Therapeutics, Inc. | 106.82M | -3.53% | 2,587,595 | - |
| 356 | QTTB | Q32 Bio Inc. | 106.06M | 1.54% | 413,544 | 53.74M |
| 357 | CRDF | Cardiff Oncology, Inc. | 105.97M | -7.19% | 614,497 | 593.00K |
| 358 | TTRX | Turn Therapeutics Inc. | 101.88M | 1.76% | 36,508 | - |
| 359 | KPTI | Karyopharm Therapeutics Inc. | 100.52M | -1.62% | 802,698 | 146.07M |
| 360 | RANI | Rani Therapeutics Holdings, Inc. | 100.26M | -24.94% | 3,588,990 | 1.63M |
| 361 | BMEA | Biomea Fusion, Inc. | 95.44M | -3.65% | 1,830,881 | - |
| 362 | SEER | Seer, Inc. | 93.09M | -2.37% | 211,891 | 16.58M |
| 363 | COYA | Coya Therapeutics, Inc. | 92.89M | -5.26% | 251,300 | 7.95M |
| 364 | HURA | TuHURA Biosciences, Inc. | 92.78M | -7.18% | 581,465 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 90.93M | -6.22% | 1,687,199 | - |
| 366 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 86.66M | -5.38% | 403,410 | - |
| 367 | SPRB | Spruce Biosciences, Inc. | 86.49M | -8.78% | 37,461 | 697.00K |
| 368 | VANI | Vivani Medical, Inc. | 86.34M | -5.56% | 241,895 | - |
| 369 | MCRB | Seres Therapeutics, Inc. | 86.28M | -3.54% | 32,834 | 789.00K |
| 370 | ANIX | Anixa Biosciences, Inc. | 85.83M | -2.66% | 102,353 | - |
| 371 | FBIO | Fortress Biotech, Inc. | 85.51M | -4.34% | 349,289 | 62.30M |
| 372 | PYXS | Pyxis Oncology, Inc. | 82.31M | -5.76% | 488,891 | 13.86M |
| 373 | GOSS | Gossamer Bio, Inc. | 81.32M | -7.55% | 9,373,533 | 48.47M |
| 374 | CSBR | Champions Oncology, Inc. | 79.71M | -0.86% | 10,684 | 57.95M |
| 375 | MAIA | MAIA Biotechnology, Inc. | 79.48M | -5.07% | 2,477,166 | - |
| 376 | PYPD | PolyPid Ltd. | 78.10M | -0.69% | 50,636 | - |
| 377 | KZIA | Kazia Therapeutics Limited | 78.02M | -1.38% | 177,896 | 1.27M |
| 378 | AARD | Aardvark Therapeutics, Inc. | 77.45M | 1.14% | 203,930 | - |
| 379 | GANX | Gain Therapeutics, Inc. | 77.30M | -3.17% | 889,611 | - |
| 380 | NRXS | NeurAxis, Inc. | 77.19M | -1.43% | 147,319 | 3.57M |
| 381 | PTHS | Pelthos Therapeutics Inc. | 75.47M | -1.10% | 4,626 | 16.80M |
| 382 | VRCA | Verrica Pharmaceuticals Inc. | 74.90M | -0.68% | 62,434 | 35.58M |
| 383 | CING | Cingulate Inc. | 73.84M | 1.11% | 355,927 | - |
| 384 | ATYR | aTyr Pharma, Inc. | 73.73M | -5.13% | 1,266,832 | 190.00K |
| 385 | PLRX | Pliant Therapeutics, Inc. | 73.06M | -4.07% | 715,180 | - |
| 386 | NRXP | NRx Pharmaceuticals, Inc. | 72.42M | -7.98% | 782,009 | 1.23M |
| 387 | GRCE | Grace Therapeutics, Inc. | 72.11M | -2.31% | 517,169 | - |
| 388 | GUTS | Fractyl Health, Inc. | 71.17M | -5.20% | 2,308,314 | 3.00K |
| 389 | PMVP | PMV Pharmaceuticals, Inc. | 69.86M | -2.96% | 267,743 | - |
| 390 | XBIT | XBiotech Inc. | 69.21M | -1.73% | 77,580 | - |
| 391 | MNOV | MediciNova, Inc. | 67.68M | -3.17% | 41,220 | 409.66K |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 66.46M | -2.20% | 27,368 | 1.36M |
| 393 | DWTX | Dogwood Therapeutics, Inc. | 66.14M | -4.81% | 79,581 | - |
| 394 | IFRX | InflaRx N.V. | 65.92M | -1.95% | 250,408 | 34.44K |
| 395 | CGTX | Cognition Therapeutics, Inc. | 65.24M | -32.40% | 7,006,273 | - |
| 396 | BYSI | BeyondSpring Inc. | 64.97M | -1.86% | 20,537 | 1.88M |
| 397 | ACET | Adicet Bio, Inc. | 62.18M | -3.71% | 99,653 | - |
| 398 | IBO | Impact BioMedical Inc. | 61.98M | 1.79% | 135,422 | 32.00K |
| 399 | IBIO | iBio, Inc. | 60.80M | 1.15% | 1,255,565 | 300.00K |
| 400 | EXOZ | eXoZymes, Inc. | 59.97M | -1.11% | 5,571 | -700.00 |
| 401 | ICCC | ImmuCell Corporation | 58.98M | -0.15% | 9,308 | 27.64M |
| 402 | ANVS | Annovis Bio, Inc. | 57.56M | -5.58% | 709,722 | - |
| 403 | ATHE | Alterity Therapeutics Limited | 57.28M | - | 4,713 | 4.43M |
| 404 | TCRX | TScan Therapeutics, Inc. | 56.25M | -4.03% | 451,006 | 10.33M |
| 405 | OKUR | OnKure Therapeutics, Inc. | 54.56M | -13.07% | 7,009,612 | - |
| 406 | TIL | Instil Bio, Inc. | 53.65M | -5.38% | 70,932 | - |
| 407 | IMA | ImageneBio, Inc. | 53.27M | -7.41% | 169,681 | 800.00K |
| 408 | HYFT | MindWalk Holdings Corp. | 53.14M | -7.76% | 424,875 | 20.70M |
| 409 | MREO | Mereo BioPharma Group plc | 52.53M | -2.89% | 1,415,867 | 500.00K |
| 410 | IMMP | Immutep Limited | 52.29M | -1.08% | 424,798 | 5.28M |
| 411 | LPCN | Lipocine Inc. | 51.97M | -3.78% | 63,735 | 1.98M |
| 412 | INKT | MiNK Therapeutics, Inc. | 51.73M | 14.43% | 225,724 | - |
| 413 | ACRV | Acrivon Therapeutics, Inc. | 51.53M | -6.34% | 588,396 | - |
| 414 | ENTX | Entera Bio Ltd. | 51.36M | 8.74% | 120,509 | 124.00K |
| 415 | ACTU | Actuate Therapeutics, Inc. | 50.98M | -5.29% | 35,064 | - |
| 416 | MGX | Metagenomi Therapeutics, Inc. | 49.66M | -5.04% | 260,801 | 25.21M |
| 417 | OSTX | OS Therapies Incorporated | 49.65M | 2.92% | 584,535 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 49.21M | -2.00% | 82,512 | 10.86M |
| 419 | EDSA | Edesa Biotech, Inc. | 48.59M | -0.68% | 211,292 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 48.11M | -4.15% | 24,809 | 43.77M |
| 421 | NTRB | Nutriband Inc. | 46.94M | 1.30% | 8,886 | 2.28M |
| 422 | KZR | Kezar Life Sciences, Inc. | 45.40M | -2.36% | 26,996 | - |
| 423 | LSTA | Lisata Therapeutics, Inc. | 45.34M | - | 14,253 | 170.00K |
| 424 | RLYB | Rallybio Corporation | 43.06M | -3.55% | 61,969 | 858.00K |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -0.79% | 71,806 | - |
| 426 | RNXT | RenovoRx, Inc. | 41.41M | -2.59% | 516,988 | 928.00K |
| 427 | GOVX | GeoVax Labs, Inc. | 41.18M | -2.84% | 52,450 | 3.35M |
| 428 | ALGS | Aligos Therapeutics, Inc. | 40.90M | -6.11% | 55,740 | 2.19M |
| 429 | LITS | Lite Strategy, Inc. | 40.73M | -3.45% | 385,844 | - |
| 430 | ATOS | Atossa Therapeutics, Inc. | 40.65M | 0.21% | 64,076 | - |
| 431 | DCOY | Decoy Therapeutics Inc. | 40.19M | -10.32% | 12,043 | - |
| 432 | NBY | NovaBay Pharmaceuticals, Inc. | 39.94M | -1.96% | 217,172 | 10.30M |
| 433 | ESLA | Estrella Immunopharma, Inc. | 39.65M | 0.96% | 37,327 | - |
| 434 | PSTV | Plus Therapeutics, Inc. | 39.46M | -5.31% | 3,506,523 | 5.21M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 37.94M | -9.54% | 374,533 | 1.14M |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 37.54M | -2.55% | 48,075 | 120.77M |
| 437 | PTN | Palatin Technologies, Inc. | 37.22M | -3.20% | 9,456 | 8.96M |
| 438 | APLM | Apollomics, Inc. | 37.06M | -2.07% | 4,466 | 6.93M |
| 439 | RNTX | Rein Therapeutics Inc. | 35.89M | 0.79% | 47,225 | - |
| 440 | NXTC | NextCure, Inc. | 35.64M | -1.18% | 20,604 | - |
| 441 | LONA | LeonaBio, Inc. | 35.38M | -7.33% | 53,042 | - |
| 442 | CELU | Celularity Inc. | 35.18M | 1.67% | 22,189 | 40.58M |
| 443 | SNSE | Sensei Biotherapeutics, Inc. | 34.92M | 2.98% | 88,866 | - |
| 444 | CRVO | CervoMed Inc. | 34.44M | -5.10% | 51,304 | 4.01M |
| 445 | VERU | Veru Inc. | 33.87M | -5.38% | 80,153 | 16.89M |
| 446 | PLUR | Pluri Inc. | 32.56M | 0.62% | 1,859 | 1.34M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 32.13M | -1.90% | 181,410 | 90.00K |
| 448 | JSPR | Jasper Therapeutics, Inc. | 29.80M | -4.05% | 523,820 | - |
| 449 | INMB | INmune Bio Inc. | 29.78M | -6.67% | 354,238 | 50.00K |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 29.74M | -4.80% | 32,685 | - |
| 451 | TLSA | Tiziana Life Sciences Ltd | 29.47M | -0.80% | 179,828 | - |
| 452 | BCTX | BriaCell Therapeutics Corp. | 28.17M | -3.60% | 302,075 | - |
| 453 | XCUR | Exicure, Inc. | 28.11M | -4.34% | 16,060 | 500.00K |
| 454 | SER | Serina Therapeutics, Inc. | 27.95M | -13.03% | 720,448 | 130.00K |
| 455 | HYPD | Hyperion DeFi, Inc. | 27.69M | -2.01% | 223,939 | 813.46K |
| 456 | CVM | CEL-SCI Corporation | 27.07M | -7.78% | 57,906 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 26.95M | 1.83% | 30,723 | 6.44M |
| 458 | PDSB | PDS Biotechnology Corporation | 26.52M | -15.42% | 984,492 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.69M | -4.72% | 75,013 | 797.92K |
| 460 | DYAI | Dyadic International, Inc. | 24.73M | -3.21% | 206,014 | 3.09M |
| 461 | BOLD | Boundless Bio, Inc. | 24.69M | -0.72% | 156,528 | - |
| 462 | SNTI | Senti Biosciences, Inc. | 24.61M | -10.36% | 243,340 | 22.00K |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 24.41M | -5.06% | 114,131 | - |
| 464 | IGC | IGC Pharma, Inc. | 23.71M | -1.96% | 275,868 | 1.11M |
| 465 | TPST | Tempest Therapeutics, Inc. | 23.25M | 3.92% | 325,323 | - |
| 466 | CUE | Cue Biopharma, Inc. | 22.96M | -6.30% | 802,728 | 27.47M |
| 467 | DARE | Daré Bioscience, Inc. | 22.57M | 2.65% | 259,928 | 1.03M |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 22.56M | -5.87% | 528,297 | 789.00K |
| 469 | BRNS | Barinthus Biotherapeutics plc | 22.47M | 0.04% | 4,464 | 14.97M |
| 470 | CRIS | Curis, Inc. | 22.21M | -4.22% | 457,070 | 9.44M |
| 471 | QNTM | Quantum BioPharma Ltd. | 22.17M | 24.54% | 422,283 | - |
| 472 | XTLB | XTL Biopharmaceuticals Ltd. | 22.12M | -4.56% | 6,542 | 968.00K |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 21.71M | -4.11% | 45,622 | 14.99M |
| 474 | MRKR | Marker Therapeutics, Inc. | 21.68M | -3.70% | 88,151 | 3.55M |
| 475 | LGVN | Longeveron Inc. | 21.41M | -5.44% | 562,603 | 1.20M |
| 476 | PASG | Passage Bio, Inc. | 20.63M | -6.68% | 47,135 | - |
| 477 | NNVC | NanoViricides, Inc. | 19.58M | -5.59% | 143,615 | - |
| 478 | VYNE | VYNE Therapeutics Inc. | 19.54M | -4.26% | 131,339 | 570.00K |
| 479 | PLRZ | Polyrizon Ltd. | 19.30M | -12.73% | 35,656 | - |
| 480 | SKYE | Skye Bioscience, Inc. | 19.26M | -6.63% | 615,548 | - |
| 481 | LEXX | Lexaria Bioscience Corp. | 18.47M | -1.08% | 135,813 | 522.00K |
| 482 | LIXT | Lixte Biotechnology Holdings, Inc. | 17.63M | 4.22% | 61,283 | - |
| 483 | OTLK | Outlook Therapeutics, Inc. | 17.32M | -0.71% | 1,907,248 | 205.70K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.09M | -4.88% | 67,803 | - |
| 485 | ALLR | Allarity Therapeutics, Inc. | 16.92M | - | 149,131 | - |
| 486 | AEON | AEON Biopharma, Inc. | 16.01M | 16.00% | 289,993 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 15.98M | 2.87% | 256,579 | 3.94M |
| 488 | INTS | Intensity Therapeutics, Inc. | 15.32M | -1.31% | 4,937 | - |
| 489 | PHIO | Phio Pharmaceuticals Corp. | 14.62M | -0.13% | 277,796 | - |
| 490 | COCP | Cocrystal Pharma, Inc. | 14.20M | - | 21,849 | - |
| 491 | TRAW | Traws Pharma, Inc. | 14.14M | -8.29% | 66,147 | 2.85M |
| 492 | IOBT | IO Biotech, Inc. | 13.89M | -5.85% | 642,709 | - |
| 493 | INAB | IN8bio, Inc. | 13.79M | -4.76% | 82,621 | - |
| 494 | GNTA | Genenta Science S.p.A. | 13.59M | -14.29% | 1,147,635 | - |
| 495 | FBLG | FibroBiologics, Inc. | 13.29M | -10.64% | 1,479,050 | - |
| 496 | MBRX | Moleculin Biotech, Inc. | 13.02M | 0.41% | 64,876 | - |
| 497 | GTBP | GT Biopharma, Inc. | 12.90M | -8.32% | 1,086,407 | - |
| 498 | BCDA | BioCardia, Inc. | 12.80M | -0.85% | 40,090 | 3.00K |
| 499 | CDT | CDT Equity Inc. | 12.79M | -20.06% | 106,063 | - |
| 500 | LTRN | Lantern Pharma Inc. | 12.53M | -46.41% | 7,346,084 | - |